Home › Waldenstrom Macroglobulinemia › New Jersey › Edison
Waldenstrom Macroglobulinemia clinical trials in Edison, NJ
6 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Astera Cancer Care ( Site 2732), East Brunswick · 6 mi away
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RecruitingPhase 1
- START New Jersey, East Brunswick · 6 mi away
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi away
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- New York City, NY6 studies
- Dallas, TX6 studies
- Houston, TX6 studies
- Rochester, MN5 studies
- Seattle, WA5 studies
- Milwaukee, WI5 studies
- Queens, NY4 studies
- Columbus, OH4 studies
- Baldwin Park, CA4 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.